Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey

Autor: Tahar Chouihed, Pierre Nazeyrollas, Bruno Maillier, James L. Januzzi, Nicolas Girerd, Alexandre Mebazaa, Pascal Bilbault, William T. Abraham, François Braun, Stefano Coiro, Ludivine Fillieux, David Kenizou, Gérard Roul, Faiez Zannad, Marie-France Seronde, Patrick Rossignol, Laurent Sebbag
Přispěvatelé: Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( EA 3920) (PCVP / CARDIO), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Department of Medicine [Perugia, Italy], Università degli Studi di Perugia (UNIPG), Service d’Accueil des urgences [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Les Hôpitaux Universitaires de Strasbourg (HUS), Stress vasculaire et tissulaire en transplantation : microparticules et environnement, Université de Strasbourg (UNISTRA), Centre hospitalier régional Metz-Thionville (CHR Metz-Thionville), Centre Hospitalier Emile Muller [Mulhouse] (CH E.Muller Mulhouse), Groupe Hospitalier de Territoire Haute Alsace (GHTHA), CH de Troyes, Centre Hospitalier Universitaire de Reims (CHU Reims), Nouvel Hôpital Civil Strasbourg, Novartis Pharma SAS, Davis Heart and Lung Research Institute, Center for Biomedical EPR Spectroscopy and Imaging, Ohio State University [Columbus] (OSU), Massachusetts General Hospital [Boston], Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpitaux Universitaires Saint-Louis, Lariboisière, Fernand-Widal, Université Paris Diderot - Paris 7 (UPD7), Biomarqueurs CArdioNeuroVASCulaires (BioCANVAS), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-Nancy, Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy]-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)-Université de Franche-Comté (UFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL)
Rok vydání: 2018
Předmět:
Emergency Medical Services
task-force
[SDV]Life Sciences [q-bio]
Aftercare
heart failure
030204 cardiovascular system & hematology
Weight Gain
association hfa
law.invention
0302 clinical medicine
Randomized controlled trial
high-risk
Multidisciplinary approach
law
Natriuretic Peptide
Brain
030212 general & internal medicine
Lung
ComputingMilieux_MISCELLANEOUS
lung ultrasound
Edema
Cardiac
cardiovascular
congestion
Water-Electrolyte Balance
Prognosis
Patient Discharge
Telemedicine
3. Good health
Patient management
randomized clinical-trial
Echocardiography
Disease Progression
reduced ejection fraction
Medical emergency
Emergency Service
Hospital
Cardiology and Cardiovascular Medicine
hospitalization
Pulmonary Edema
Vena Cava
Inferior
european-society
03 medical and health sciences
Congestion detection
medicine
Humans
prognostic value
In patient
plasma volume
natriuretic peptide
business.industry
biomarkers
Emergency department
medicine.disease
mortality
Peptide Fragments
Dyspnea
Heart failure
Cardiovascular System & Cardiology
natriuretic
peptides
business
Zdroj: JACC: Heart Failure
JACC: Heart Failure, Elsevier/American College of Cardiology, 2018, 6 (4), pp.273-285. ⟨10.1016/j.jchf.2017.09.023⟩
ISSN: 2213-1779
DOI: 10.1016/j.jchf.2017.09.023
Popis: International audience; Congestion is one of the main predictors of poor patient outcome in patients with heart failure. However, congestion is difficult to assess, especially when symptoms are mild. Although numerous clinical scores, imaging tools, and biological tests are available to assist physicians in ascertaining and quantifying congestion, not all are appropriate for use in all stages of patient management. In recent years, multidisciplinary management in the community has become increasingly important to prevent heart failure hospitalizations. Electronic alert systems and communication platforms are emerging that could be used to facilitate patient home monitoring that identifies congestion from heart failure decompensation at an earlier stage. This paper describes the role of congestion detection methods at key stages of patient care: pre-admission, admission to the emergency department, in-hospital management, and lastly, discharge and continued monitoring in the community. The multidisciplinary working group, which consisted of cardiologists, emergency physicians, and a nephrologist with both clinical and research backgrounds, reviewed the current literature regarding the various scores, tools, and tests to detect and quantify congestion. This paper describes the role of each tool at key stages of patient care and discusses the advantages of telemedicine as a means of providing true integrated patient care. (c) 2018 Published by Elsevier on behalf of the American College of Cardiology Foundation.
Databáze: OpenAIRE
Externí odkaz: